China's NEO brain implant just did what no other BCI has managed — it cleared commercial approval and is already helping paralyzed patients control robotic gloves at home. The epidural design sidesteps the scarring risks of deeper implants while still delivering real, lasting results. While American companies chase perfect signals, China threaded a working product through regulators and into people's lives.
China's rush to commercialize the first BCI implant raises serious concerns about long-term safety. While it may help some patients short-term, the lack of rigorous independent oversight compared to FDA processes risks unforeseen complications, turning vulnerable people into test cases
A brain implant collecting neural signals raises questions that go far beyond the operating room — who owns that data, and what stops it from becoming a surveillance pipeline? Hackers could theoretically access neural data or manipulate motor signals, turning a medical device into a serious safety threat. The medical potential is real, but rock-solid privacy protections and cybersecurity need to be built in from day one, not patched in later.
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.7.2